Akebia Therapeutics, Inc.

Q2 2019 13F Holders

Symbol
AKBA
CUSIP
00972D105
Type
Equity
Class
COM
Num filings
169
Total reported value, excl. options
$419 M
Manager Report Date Value ($000) Shares Option Type